Buscar
Mostrando ítems 1-10 de 12
The Falling Incidence of Hematologic Cancer After Heart Transplantation
(Wiley, 2014-10-01)
[Abstract] Background. A number of changes in the management of heart transplantation (HT) patients have each tended to reduce the risk of post-HT hematologic cancer, but little information is available concerning the ...
Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: a multicenter prospective study
(Elsevier, 2017)
[Abstract] BACKGROUND: New biomarkers are necessary to improve detection of the risk of infection in heart transplantation. We performed a multicenter study to evaluate humoral immunity profiles that could better enable ...
Venous thromboembolism in heart transplant recipients: Incidence, recurrence and predisposing factors
(Elsevier para International Society for Heart and Lung Transplantation, 2015-10-02)
[Abstract] Background. A high frequency of venous thromboembolism (VTE) has been observed after lung, kidney, and liver transplantation. However, data about the incidence of this complication among heart transplant (HT) ...
Circulating miR-181a-5p as a New Biomarker for Acute Cellular Rejection in Heart Transplantation
(Elsevier, 2020-06-07)
[Abstract] Background: Acute cellular rejection (ACR) is a major complication in heart transplantation (HTx). Endomyocardial biopsy is the reference method for early detection of ACR, but a new non-invasive approach is ...
Usefulness of the INTERMACS scale for predicting outcomes after urgent heart transplantation
(Elsevier, 2011)
[Abstract] Introduction and objectives. Our aim was to assess the prognostic value of the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support) scale in patients undergoing urgent heart transplantation ...
Chronic anemia in heart transplant patients: prevalence, risk factors, and prognostic significance
(Elsevier, 2007)
[Abstract] Introduction and objectives. Data on chronic anemia following heart transplantation (HT) are scarce and contradictory. Our aims were to determine the prevalence of chronic anemia after HT, to identify predisposing ...
Gene expression profiling for monitoring graft rejection in heart transplant recipients
(Elsevier, 2009-08-26)
[Abstract] Heart transplantation is a life-prolonging therapy for many patients with stage D heart failure and other forms of advanced heart disease. However, graft rejection and/or immunosuppression-related side effects ...
In-hospital postoperative infection after heart transplantation: risk factors and development of a novel predictive score
(Wiley, 2019-05-11)
[Abstract] Introduction: Infection is one of the most significant complications following heart transplantation (HT). The aim of this study was to identify specific risk factors for early postoperative infections in HT ...
Polymorphisms in genes related to the complement system and antibody-mediated cardiac allograft rejection
(Elsevier, 2017-07-15)
[Abstract] Background. Heart transplantation (HT) is a life-saving treatment for patients with end-stage heart failure. One of the main problems after HT is the humoral response termed antibody-mediated rejection (AMR). ...
Epidemiological study of tricuspid regurgitation after cardiac transplantation: does it influence survival?
(Frontiers, 2022-03-21)
[Abstract] Background: Tricuspid valve disease is the most frequent valvulopathy after heart transplantation (HTx). Evidence for the negative effect of post-transplant tricuspid regurgitation (TR) on survival is contradictory. ...